recombinant aspartylglucosaminidase therapy(ACE Biosciences)

N/A

Report date: 2025/01/26 17:50:28

Base Information

Drug Namerecombinant aspartylglucosaminidase therapy(ACE Biosciences)
Drug Alias Namerecombinant aspartylglucosaminidase therapy (Zymenex)recombinant aspartylglucosaminidase therapy(Chiesi)
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionEnzymes stimulants
TargetsEnzymes
Therapy Area/IndicationsLysosomal Storage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAce Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesAce Biosciences
Inactive CompaniesN/A
Active IndicationsLysosomal Storage Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A